1394002-56-2

Upstream product

• 105640-07-1 4-(4-hydroxyphenyl)cyclohexan-1-one 
• 1109277-50-0 methyl (trans-4-{4-[(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)amino]phenyl}cyclohexyl)acetate 
• 313339-35-4 4,6-dichloro-2-(methylsulfanyl)pyrimidine-5-carboxylic acid 
• 701232-66-8 [4-(4-hydroxyphenyl)cyclohexylidene]acetic acid methyl ester 
• 701232-67-9 trans-[4-(4-hydroxyphenyl)cyclohexyl]acetic methyl ester 
• 701232-68-0 (trans)-methyl 2-(4-(4-(((trifluoromethyl)sulfonyl)oxy)phenyl)cyclohexyl)acetate 

Downstream Products

• 1394002-57-3 methyl (trans-4-{4-[{[4,6-dichloro-2-(methylsulfanyl)pyrimidin-5-yl]carbonyl}(2-hydroxyethyl)amino]phenyl}cyclohexyl)acetate 
• 1394002-58-4 methyl (trans-4-{4-[4-chloro-2-(methylsulfanyl)-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl]phenyl}cyclohexyl)acetate 
• 1394002-59-5 methyl (trans-4-{4-[4-amino-2-(methylsulfanyl)-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl]phenyl}cyclohexyl)acetate 
• 1394002-60-8 (trans-4-{4-[4-amino-2-(methylsulfanyl)-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl]phenyl}cyclohexyl)acetic acid 
• 1394002-61-9 (trans-4-{4-[4-amino-2-(methylsulfonyl)-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl]phenyl}cyclohexyl)acetic acid 
• 1398551-70-6 (trans-4-{4-[4-amino-2-(3-methylbutoxy)-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl]phenyl}cyclohexyl)acetic acid trifluoroacetate 

Relevant academic research and scientific papers

4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5, 4 -F] [1, 4] OXAZEPINE COMPOUNDS AS DGAT1 INHIBITORS

Described herein are compounds of formula (I). The compounds of formula (I) act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.

LACTAM DERIVATIVES AS DGAT-1 INHIBITORS

Described herein are compounds of formula I The compounds of formula I act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.